BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2018
View Archived Issues
First patient treated in phase I study of anti-CD47 monoclonal antibody SRF-231
Read More
Eli Lilly discovers novel PDE1 inhibitors
Read More
Novel serine protease HTRA1 inhibitors identified at Roche
Read More
Genentech and Roche present new HsNIK inhibitors
Read More
Technical University of Denmark presents ROS-activated methotrexate and aminopterin prodrugs
Read More
GlaxoSmithKline divulges novel bromodomain and extra-terminal protein inhibitors
Read More
DHX34 expression predicts poor survival in melanoma patients
Read More
SAR-191801, an orally active inhibitor of H-PGDS for asthma and COPD
Read More
Cosmo Pharmaceuticals submits NDA to the FDA or rifamycin SV MMX
Read More
First patient dosed in phase II psoriasis trial of ABY-035
Read More
Eiger BioPharmaceuticals receives FDA guidance for lornafarnib HDV development
Read More
Biodesix to collaborate with Checkmate Pharmaceuticals on treatment biomarkers
Read More
Researchers discover novel phyllanthusmin analog PHY-34
Read More
FDA grants fast track designation to Pedmark
Read More
Inhaled JAK1 inhibitors synthesized for treating asthma
Read More
Helix BioPharma and ProMab Biotechnologies to collaborate on CAR-T therapy
Read More
Swedish Orphan Biovitrum launches Ravicti in Europe
Read More
Boston Scientific to acquire NxThera
Read More
AOBiome Therapeutics' ammonia oxidizing bacteria product well tolerated in phase I study
Read More
New gene fusions detected in pleomorphic adenoma
Read More
Merus and Vall d'Hebron Institute of Oncology expand collaboration
Read More
Deinove enters option and license agreement for Redx's anti-infective program
Read More
Innate Biologics to develop recombinant protein platform with the Wistar Institute
Read More
Novartis signs licensing agreement for Harvard's biomaterial-based cancer immunotherapies
Read More
LSZ-102, a potent SERD showing good oral bioavailability and clinical safety
Read More
Bayer's acquisition of Monsanto gets conditional approval in Europe
Read More
Allysta initiates phase I/II study of H-1337 for elevated intraocular pressure
Read More
Bristol-Myers Squibb studies BMS-986258 alone and with nivolumab in advanced solid tumors
Read More
GlaxoSmithKline initiates first-in-human study of GSK-3358699
Read More